Literature DB >> 7539210

CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens.

N Rave-Harel1, I Madgar, R Goshen, M Nissim-Rafinia, A Ziadni, A Rahat, O Chiba, Y M Kalman, C Brautbar, D Levinson.   

Abstract

Congenital bilateral aplasia of the vas deferens (CBAVD) was suggested to be a mild form of cystic fibrosis (CF). Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in males with CBAVD revealed that in some males CBAVD is caused by two defective CFTR alleles. The genetic basis of CBAVD in the other males and its association with CF remained unclear. We undertook this study to test the hypothesis of commonality of CBAVD and CF by haplotype analysis, in the CFTR locus, of males suffering from CBAVD and of their families. According to the hypothesis of commonality of CBAVD and CF, two brothers with CBAVD are expected to carry the same two CFTR alleles, while their fertile brothers are expected to carry at least one different allele. Eleven families were studied, of which two families, with unidentified CFTR mutations, did not support this hypothesis. In these families two brothers with CBAVD inherited different CFTR alleles. Their fertile brothers inherited the same CFTR alleles as their brothers with CBAVD. These results provide evidence for genetic heterogeneity in CBAVD. Though in some families CBAVD is associated with two CFTR mutations, we suggest that in others it is caused by other mechanisms, such as mutations at other loci or homozygosity or heterozygosity for partially penetrant CFTR mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539210      PMCID: PMC1801105     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  41 in total

1.  Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families.

Authors:  T Dörk; T Neumann; U Wulbrand; B Wulf; N Kälin; G Maass; M Krawczak; H Guillermit; C Ferec; G Horn
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

2.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

Authors:  B S Kerem; J Zielenski; D Markiewicz; D Bozon; E Gazit; J Yahav; D Kennedy; J R Riordan; F S Collins; J M Rommens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Methods for analysis of multiple cystic fibrosis mutations.

Authors:  I S Ng; R Pace; M V Richard; K Kobayashi; B Kerem; L C Tsui; A L Beaudet
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

4.  Characterization and rapid diagnostic analysis of DNA polymorphisms closely linked to the cystic fibrosis locus.

Authors:  G T Horn; B Richards; J J Merrill; K W Klinger
Journal:  Clin Chem       Date:  1990-09       Impact factor: 8.327

5.  A dimorphic 4-bp repeat in the cystic fibrosis gene is in absolute linkage disequilibrium with the delta F508 mutation: implications for prenatal diagnosis and mutation origin.

Authors:  F F Chehab; J Johnson; E Louie; M Goossens; E Kawasaki; H Erlich
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

6.  A mutation in the second nucleotide binding fold of the cystic fibrosis gene.

Authors:  L Osborne; R Knight; G Santis; M Hodson
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

7.  Congenital absence of the vas deferens. The fertilizing capacity of human epididymal sperm.

Authors:  S J Silber; T Ord; J Balmaceda; P Patrizio; R H Asch
Journal:  N Engl J Med       Date:  1990-12-27       Impact factor: 91.245

8.  Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; D Bozon; B Kerem; D Markiewicz; P Durie; J M Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

9.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

10.  Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

Authors:  T Shoshani; A Augarten; E Gazit; N Bashan; Y Yahav; Y Rivlin; A Tal; H Seret; L Yaar; E Kerem
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

View more
  8 in total

1.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis.

Authors:  P W Miller; A Hamosh; M Macek; P A Greenberger; J MacLean; S M Walden; R G Slavin; G R Cutting
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  CFTR Gene Mutations and Asthma in Indian Children: A Case-Control Study.

Authors:  Pratibha Dixit; Shally Awasthi; Nutan Maurya; Sarita Agarwal; M Srinivasan
Journal:  Indian J Clin Biochem       Date:  2013-11-22

3.  The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

Authors:  N Rave-Harel; E Kerem; M Nissim-Rafinia; I Madjar; R Goshen; A Augarten; A Rahat; A Hurwitz; A Darvasi; B Kerem
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

4.  Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations.

Authors:  Konstantinos Douros; Ioanna Loukou; Stavros Doudounakis; Maria Tzetis; Kostas N Priftis; Emmanuel Kanavakis
Journal:  Int J Clin Exp Med       Date:  2008-10-27

5.  How is the Human Genome Project doing, and what have we learned so far?

Authors:  M S Guyer; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Counseling and screening for cystic fibrosis in patients with congenital bilateral absence of the vas deferens: Patient perceptions.

Authors:  J L Fitzpatrick; E M Hutton; R Babul; C S Cytrynbaum; J E Sutherland; C T Shuman
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

7.  Major-locus contributions to variability of the craniofacial feature dystopia canthorum in Waardenburg syndrome.

Authors:  J E Reynolds; M L Marazita; J M Meyer; C A Stevens; L J Eaves; K S Arnos; L M Ploughman; C MacLean; W E Nance; S R Diehl
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

8.  Identification of pleiotropy at the gene level between psychiatric disorders and related traits.

Authors:  Tatiana Polushina; Niladri Banerjee; Sudheer Giddaluru; Francesco Bettella; Thomas Espeseth; Astri J Lundervold; Srdjan Djurovic; Sven Cichon; Per Hoffmann; Markus M Nöthen; Vidar M Steen; Ole A Andreassen; Stéphanie Le Hellard
Journal:  Transl Psychiatry       Date:  2021-07-29       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.